GC Green Cross and Thai Red Cross Society Sign Strategic Partnership MOU

Training and Educational Collaboration for Plasma Fractionation Specialists

On August 18, GC Green Cross announced that it has signed a strategic memorandum of understanding (MOU) with the Thai Red Cross Society to collaborate on training and developing specialized personnel for plasma fractionation products.

Hyungjun Park, Head of GC Green Cross Ochang Plant (left), and Chaiwanich Siri, Director of the Thai Red Cross Blood Center (right), are taking a commemorative photo after signing the MOU. GC Green Cross

This MOU was achieved as a result of the ongoing close relationship between GC Green Cross and the Thai Red Cross Society since GC Green Cross exported a plasma fractionation plant to Thailand in 2015. Through the MOU, the two organizations will jointly plan and operate on-site training and internship programs for local production staff. The company explained that these programs are intended to transfer GC Green Cross's advanced technologies and production expertise.

In addition, both parties plan to continuously identify and expand various cooperation opportunities that align with their mutual strengths and interests. They also expect to gradually broaden the scope of collaboration by exploring potential joint projects, such as the transfer of new plasma byproduct processing technologies.

Chaiwanich Siri, Director of the Thai Red Cross Blood Center, stated, "Strengthening the capabilities of local personnel through GC Green Cross's specialized training is essential for maintaining the quality, safety, and continuity of plasma fractionation product manufacturing in Thailand. This collaboration will serve as a significant milestone not only for human resource development but also for technology transfer."

Hyungjun Park, Head of GC Green Cross Ochang Plant, commented, "Through this partnership, we aim to spread GC Green Cross's advanced production technologies and quality standards throughout Asia. Based on our cooperation with the Thai Red Cross Society, we will pursue mutual growth and the public good together."

Meanwhile, GC Green Cross is accelerating its global expansion by entering the United States, the world's largest immunoglobulin market, and by expanding its business into Southeast Asian countries where self-sufficient plasma fractionation systems have not yet been established.

This content was produced with the assistance of AI translation services.